8.41
-0.08 (-0.94%)
| Previous Close | 8.49 |
| Open | 8.50 |
| Volume | 202,306 |
| Avg. Volume (3M) | 590,320 |
| Market Cap | 440,290,720 |
| Price / Earnings (Forward) | 10.63 |
| Price / Sales | 7.55 |
| Price / Book | 1.36 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2026 |
| Profit Margin | -79.94% |
| Operating Margin (TTM) | -2,318.99% |
| Diluted EPS (TTM) | -2.05 |
| Quarterly Revenue Growth (YOY) | 5,556.00% |
| Total Debt/Equity (MRQ) | 2.33% |
| Current Ratio (MRQ) | 9.00 |
| Operating Cash Flow (TTM) | -130.36 M |
| Levered Free Cash Flow (TTM) | -35.38 M |
| Return on Assets (TTM) | -15.49% |
| Return on Equity (TTM) | -23.46% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Prothena Corporation plc | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -2.5 |
| Price Volatility | 0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.5 |
| Average | -1.75 |
|
Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 18.99% |
| % Held by Institutions | 74.34% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rubric Capital Management Lp | 31 Mar 2026 | 5,000,000 |
| Palo Alto Investors Lp | 31 Mar 2026 | 1,208,568 |
| Jacobs Levy Equity Management, Inc | 31 Mar 2026 | 972,017 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| ISAACS MICHAEL JOHN | - | 8.56 | -13,080 | -111,965 |
| KINGSTON ANNE EVANS | - | 8.56 | -11,160 | -95,530 |
| KINNEY GENE G. | - | 8.56 | -84,000 | -719,040 |
| NGUYEN TRAN | - | 8.56 | -57,000 | -487,920 |
| SMITH BRANDON S. | - | 8.56 | -78,000 | -667,680 |
| SWANSON CHAD J. | - | 8.56 | -44,267 | -378,926 |
| WALKER KARIN L | - | 8.56 | -15,000 | -128,400 |
| ZAGO WAGNER M. | - | 8.56 | -51,000 | -436,560 |
| Aggregate Net Quantity | -353,507 | |||
| Aggregate Net Value ($) | -3,026,020 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 8.56 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| ISAACS MICHAEL JOHN | Officer | 29 Jul 2026 | Automatic sell (-) | 8,386 | 8.56 | 71,784 |
| KINGSTON ANNE EVANS | Officer | 29 Jul 2026 | Automatic sell (-) | 7,662 | 8.56 | 65,587 |
| ISAACS MICHAEL JOHN | Officer | 28 Jul 2026 | Disposed (-) | 4,694 | 8.56 | 40,181 |
| KINGSTON ANNE EVANS | Officer | 28 Jul 2026 | Disposed (-) | 3,498 | 8.56 | 29,943 |
| KINNEY GENE G. | Officer | 28 Jul 2026 | Disposed (-) | 84,000 | 8.56 | 719,040 |
| KINNEY GENE G. | Officer | 28 Jul 2026 | Option execute | 84,000 | - | - |
| NGUYEN TRAN | Officer | 28 Jul 2026 | Disposed (-) | 57,000 | 8.56 | 487,920 |
| NGUYEN TRAN | Officer | 28 Jul 2026 | Option execute | 57,000 | - | - |
| SMITH BRANDON S. | Officer | 28 Jul 2026 | Disposed (-) | 78,000 | 8.56 | 667,680 |
| SMITH BRANDON S. | Officer | 28 Jul 2026 | Option execute | 78,000 | - | - |
| SWANSON CHAD J. | Officer | 28 Jul 2026 | Disposed (-) | 44,267 | 8.56 | 378,926 |
| SWANSON CHAD J. | Officer | 28 Jul 2026 | Option execute | 51,000 | - | - |
| WALKER KARIN L | Officer | 28 Jul 2026 | Disposed (-) | 15,000 | 8.56 | 128,400 |
| WALKER KARIN L | Officer | 28 Jul 2026 | Option execute | 15,000 | - | - |
| ZAGO WAGNER M. | Officer | 28 Jul 2026 | Disposed (-) | 51,000 | 8.56 | 436,560 |
| ZAGO WAGNER M. | Officer | 28 Jul 2026 | Option execute | 51,000 | - | - |
| Show more | ||||||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |